US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Pnina Fishman
Recent news which mentions Pnina Fishman
Can-Fite Revenue FY22 Revenue Declines 4.7%, Here Is What You Need To Know
March 30, 2023
Tickers
CANF
Tags
Benzinga
CANF
Pnina Fishman
From
Benzinga
Can-Fite Reports Revenue Growth In 2021, Provides Clinical Update
March 24, 2022
Tickers
CANF
Tags
business
Benzinga
Markets
From
Benzinga
Cannabis-Focused Biotech Company Can-Fite Reports Q3 Financial Results & Clinical Updates
November 26, 2021
Tickers
CANF
Tags
Markets
Earnings
Market News
From
Benzinga
Can-Fite Reports Drop In H1 2021 Revenue, Net Loss Down By 38% YoY
August 26, 2021
Tickers
CANF
Tags
News
Cannabis
Market News
From
Benzinga